Testicular Injury of Acrylamide in Rats and
Potential Protection of Coenzyme Q10 and Rosuvastatin
Asmaa Elsayed1, Mohamed Aboubakr1*, Fatma
Wahba Hassan2, Marwa Zakaria3, Ehab Yahya
Abdelhiee4,
Ahmed Soliman5,
Anwar El-Shafey6,7,
Ahmed Farag8, Ahmed Elfadadny9
and
Nehal Abdelmageed1
1Department
of Pharmacology, Faculty of Veterinary Medicine, Benha University,
13736 Moshtohor, Toukh, Qaliobiya, Egypt; 2Physiology
Department, Faculty of Veterinary Medicine, Cairo University, 12211
Giza, Egypt; 3Department of Pharmaceutical Production
Technology, Faculty of Applied Health Science Technology, October
Technological University, Giza, Egypt;
4Forensic
Medicine and Toxicology Department, Faculty of Veterinary Medicine,
Matrouh University, Matrouh, Egypt; 5Department of
Pharmacology, Faculty of Veterinary Medicine, Cairo University,
12211 Giza, Egypt;
6Department
of Anatomy and Embryology, Faculty of Veterinary Medicine, Benha
University, Egypt; 7Department of
Basic Veterinary Sciences,
Delta University for Science and Technology, Egypt;
8Department
of Surgery, Anesthesiology and Radiology, Faculty of Veterinary
Medicine, Zagazig University, Zagazig, Egypt;
9Department
of Animal Internal Medicine, Faculty of Veterinary Medicine,
Damanhur University, Damanhur, Egypt
*Corresponding author:
mohamed.aboubakr@fvtm.bu.edu.eg
Abstract
Acrylamide (ACR) is created when foods high in carbohydrates are heated up and
is more harmful because it produces ROS inside cells. Our research aimed to
investigate the potential of coenzyme Q10 (CoQ10) and rosuvastatin (ROSV) in
mitigating the adverse effects of testicular toxicity induced by ACR in rats. A
total of 49 male rats were distributed among 07 groups. Group 1 served as the
control and was administered normal saline orally, while Group 2 received oral
CoQ10 at a dosage of 10 mg/kg BW; Group 3, was administered ROSV (10 mg/kg/BW,
orally); group 4, received ACR orally (20 mg/kg/BW); group 5 received ACR and
CoQ10; group 6 administered ACR and ROSV; and group 7, the rats received ACR,
CoQ10, and ROSV daily for 30 days.
Acrylamide lowered serum testosterone, FSH, and LH levels, and marked elevations
in testicular MDA levels were observed alongside notable decreases in GSH, CAT
and SOD. It caused a significant reduction in the diameter of seminiferous
tubules, numbers of spermatocytes, spermatogonia, Sertoli cells, germinal
epithelium height, and a dramatic increase in lumen diameter.
Also, the testicular histopathology was disturbed by ACR, and the testicular
caspase-3 expression was considerably elevated in the ACR-treated group. In rats
exposed to ACR intoxication, CoQ10 and ROSV raised levels of antioxidant
biomarkers, lowered MDA and mitigated
alterations in serum hormonal parameters. In summary, our results suggest
that
CoQ10 and ROSV exhibit considerable protective effects against ACR-induced
testicular toxicity, attributed to their anti-oxidative properties.
To Cite This Article:
Elsayed A, Aboubakr M, Hassan FW, Zakaria M,
Abdelhiee EY, Soliman A, El-ShafeyA,
Farag A, Elfadadny A and
Abdelmageed N, 2024.
Testicular injury of acrylamide in rats and potential protection of coenzyme Q10
and rosuvastatin. Pak Vet J, 44(2): 344-351. http://dx.doi.org/10.29261/pakvetj/2024.146